1.
Efficacy and Clinical Outcomes of Remdesivir Plus Intravenous Cefepime Compared to Remdesivir Plus Intravenous Levofloxacin in Type 2 Diabetes Mellitus Iraqi Patients with COVID -19. Journal of Pharmaceutical Negative Results. 2022;13(2):82-86. Accessed June 10, 2026. https://pnrjournal.com/index.php/home/article/view/199